Authors: Kunert, Joachim
Mielke, Johanna
Title: Efficient designs for the estimation of mixed and self carryover effects
Language (ISO): en
Abstract: Biosimilars are copies of biological medicines that are developed by a competitor after the patent for the originator drug has expired. Extensive clinical trials are required to show therapeutic equivalence between the biosimilar and its reference product before a biosimilar can be sold on the market. However, even after more than 10 years of experience with biosimilars in Europe, there is still some uncertainty if the patients who are already taking the reference product can switch between the biosimilar and its reference product. One convenient way to assess the impact of switches is the analysis of mixed and self carryover effects: if the products are switchable, there should not be any difference in the carryover effects. This paper determines a series of simple designs which are highly efficient for the comparison of the mixed and self carryover effects of two treatments. The proof of efficiency is not straightforward because the information matrix of the efficient designs is not completely symmetric.
Subject Headings: A-optimality
switchability
linear model
crossover designs
biosimilars
URI: http://hdl.handle.net/2003/36819
http://dx.doi.org/10.17877/DE290R-18820
Issue Date: 2018
Appears in Collections:Sonderforschungsbereich (SFB) 823

Files in This Item:
File Description SizeFormat 
DP_0818_SFB823_Kunert_Mielke.pdfDNB301.71 kBAdobe PDFView/Open


This item is protected by original copyright



All resources in the repository are protected by copyright.